Related Experiment Video

Updated: Jun 15, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Targeting the renin angiotensin system for remission/regression of chronic kidney disease

Daniela Macconi1

  • 1Department of Biomedical Engineering, Mario Negri Institute for Pharmacological Research, Bergamo, Italy. daniela.macconi@marionegri.it

Histology and Histopathology
|March 19, 2010
PubMed

Insights

Significant advancements in understanding chronic kidney disease (CKD) mechanisms have been achieved. Targeting the renin-angiotensin system offers potential for CKD remission, demonstrating successful translational medicine.

Area of Science:

  • Nephrology
  • Translational Medicine
  • Molecular Biology

Background:

  • Chronic kidney disease (CKD) poses a significant public health challenge.
  • Understanding the cellular and molecular underpinnings of CKD progression is crucial.
  • Recent progress has been made in identifying key mechanisms driving CKD.

Purpose of the Study:

  • To review experimental and clinical evidence on targeting angiotensin II for CKD management.
  • To highlight advances in treating chronic nephropathy through renin-angiotensin system blockade.
  • To showcase the impact of translational medicine on addressing public health concerns related to kidney disease.

Main Methods:

  • Review of experimental investigations.
  • Analysis of clinical studies.
  • Focus on therapies targeting the renin-angiotensin system and angiotensin II.

Main Results:

  • Renin-angiotensin system blockade has shown promise in achieving remission or regression of chronic nephropathy for some patients.
  • Targeting angiotensin II represents a successful translational medicine approach for managing CKD.
  • Significant progress has been documented in the management of chronic kidney diseases.

Conclusions:

  • Therapies targeting angiotensin II have led to notable advances in CKD management.
  • The blockade of the renin-angiotensin system offers a viable strategy for improving patient outcomes in chronic nephropathy.
  • Translational medicine has proven effective in translating scientific discoveries into clinical applications for CKD.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...